Cargando…
Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs
Globally, COVID-19 vaccines have emerged as a boon, especially during the severe pandemic phases to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, saving millions of lives. However, mixed responses to vaccination with breakthrough challenges provided a...
Autores principales: | Maurya, Ranjeet, Shamim, Uzma, Mishra, Pallavi, Swaminathan, Aparna, Raina, Aakarshan, Tarai, Bansidhar, Budhiraja, Sandeep, Pandey, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269832/ https://www.ncbi.nlm.nih.gov/pubmed/37022180 http://dx.doi.org/10.1128/spectrum.04292-22 |
Ejemplares similares
-
Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition
por: Maurya, Ranjeet, et al.
Publicado: (2023) -
Transcriptionally active nasopharyngeal commensals and opportunistic microbial dynamics define mild symptoms in the COVID 19 vaccination breakthroughs
por: Devi, Priti, et al.
Publicado: (2023) -
Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?
por: Kanakan, Akshay, et al.
Publicado: (2022) -
Early transcriptomic host response signatures in the serum of dengue patients provides insights into clinical pathogenesis and disease severity
por: Yadav, Aanchal, et al.
Publicado: (2023) -
Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections
por: Chattopadhyay, Partha, et al.
Publicado: (2022)